References
- Antonijevic IA, Murck H, Frieboes RM, Uhr M, Steiger A. 2003. On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology 28:401–418.
- Arakane M, Castillo C, Rosero MF, Peñafiel R, Pérez-López FR, Chedraui P. 2011. Factors relating to insomnia during the menopausal transition as evaluated by the Insomnia Severity Index. Maturitas 69:157–161.
- Avis N, Stellato R, Crawford S, Bromberger J, Gan P, Cain V, Kagawa-Singer M. 2001. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic group. Soc Sci Med 52:345–356.
- Bromberger JT, Kravitz HM. 2011. Mood and menopause: Findings from the study of women's health across the nation (SWAN) over 10 years. Obstet Gynecol Clin N Am 38:609–625.
- Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. 1989. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213.
- Chedraui P, Pérez-López FR, Mendoza M, Leimberg ML, Martínez MA, Vallarino V, Hidalgo L. 2010. Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth sleepiness scale. Maturitas 65:75–80.
- Gannon L, Ekstrom B. 1993. Attitudes toward menopause: the influence of sociocultural paradigm. Psychol Women Q 17:275–288.
- Gold E. 2004. Lifestyle and demographic factors in relation to vasomotor: baseline results from the study of Women's Health Across the Nation’ (SWAN). Am J Epidemiol 159:1189–1199.
- Guidozzi F. 2013. Sleep and sleep disorders in menopausal women. Climacteric 16:214–219.
- Hirschfeld RMA, Williams JBW, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al. 2000. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 157:1873–1875.
- Ikeda T, Makita K, Ishitani K, Takamatsu K, Horiguchi F, Nozawa S. 2005. Status of climacteric symptoms among middle-aged to elderly Japanese women: comparison of general healthy women with women presenting at a menopausal clinic. J Obstet Gynaecol Res 31:164–171.
- Hormozi MR. 2007. The assessment of reliability and validity of the Persian MDQ. Dissertation. Tehran, Iran: Iran University of Medical Sciences.
- Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B, Pérez-López FR. 2012. Depressive disorders and the menopause transition. Maturitas 71:120–130.
- Lock M. 2002. Symptom reporting at menopause: a review of cross-cultural findings. J Br Menopause Soc 8:132–136.
- Melby M. 2005. Vasomotor symptom prevalence; factor analysis of climacteric symptoms in Japan. Maturitas 52:205–222.
- Monterrosa-Castro A, Marrugo-Flórez M, Romero-Pérez I, Chedraui P, Fernández-Alonso AM, Pérez-López FR. 2013. Prevalence of insomnia and related factors in a large mid-aged female Colombian sample. Maturitas 74:346–351.
- Schmidt PJ. 2005. Depression, the perimenopause, and estrogen therapy. Ann N Y Acad Sci 1052:27–40.
- SF-36. 2000. Health Survey: Manual and interpretation guide. Lincoln, RI. Quality Metric Inc.
- Shabani A, Koohi-Habibi L, Nojomi M, Chimeh M, Ghaemi SN, Soleimani N. 2009. The Persian bipolar spectrum diagnostic scale and mood disorder questionnaire in screen patients with bipolar disorders. Arch Iran Med 12:41–47.
- Stotland NL. 2002. Menopause: social expectations, women's realities. Arch Women's Meant Health 5:5–8.
- Twiss JJ, Wegner J, Hunter M, Kelsay M, Rathe-Hart M, Salado W. 2007. Perimenopausal symptoms, quality of life, and health behaviors in users and nonusers of hormone therapy. J Am Acad Nurse Pract 19:602–613.
- Weber MT, Maki PM, McDermott MP. 2013. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol.